会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • AN ULTRASONICALLY CONTROLLABLE GREASE DISPENSING TOOL
    • 超声波可控润滑脂分配工具
    • WO2011130673A3
    • 2011-12-08
    • PCT/US2011032742
    • 2011-04-15
    • UE SYSTEMS INCGOODMAN MARK ABISHOP WILLIAMMOHR GARY
    • GOODMAN MARK ABISHOP WILLIAMMOHR GARY
    • F16N29/02
    • G01M7/00G01H3/125G01M3/24G01M13/045
    • Lubrication dispensing apparatus for lubricating a device with moving parts includes lubricant reservoir, lubricant dispenser, ultrasonic detection module detecting amplitude of ultrasonic energy emitted by said device when its parts are moving and produces an signal related thereto, control module analyzes the amplitude of the signal from the ultrasonic detection module causes the dispenser to automatically dispense lubricant onto the moving parts in response to a lubricate signal until the signal indicates the ultrasonic energy produced by the device has decreased to a particular level. Programmed processor and storage memory stores base value of the detected amplitude of ultrasonic energy when the device is operating properly. Processor causes dispenser to start flow of lubricant to the device, compares the signal from the ultrasonic detection module when the parts are moving, and causes dispenser to cease flow of lubricant when the signal substantially decreases.
    • 用于润滑具有运动部件的装置的润滑分配装置包括润滑剂储存器,润滑剂分配器,超声波检测模块,当其部件移动时检测由所述装置发射的超声能量的振幅并产生与其相关的信号,控制模块分析来自 超声波检测模块使得分配器响应于润滑信号自动地将润滑剂分配到运动部件上,直到信号指示由装置产生的超声能量已经降低到特定水平。 程序处理器和存储存储器存储当设备正常工作时检测到的超声波能量振幅的基值。 处理器使分配器启动润滑剂流向设备,比较当零件移动时来自超声波检测模块的信号,并且当信号显着降低时使得分配器停止润滑剂流动。
    • 3. 发明申请
    • COMPOUNDS, COMPOSITIONS, METHODS OF SYNTHESIS, AND METHODS OF TREATMENT
    • 化合物,组合物,合成方法和治疗方法
    • WO2010096426A2
    • 2010-08-26
    • PCT/US2010/024393
    • 2010-03-12
    • EMORY UNIVERSITYSTEHOUWER, JeffGOODMAN, MarkKILTS, ClintNEMEROFF, Charles
    • STEHOUWER, JeffGOODMAN, MarkKILTS, ClintNEMEROFF, Charles
    • C07D487/04C07D403/04C07D487/14A61K49/06
    • C07F7/2208A61K51/0459A61K51/0468A61K51/0472C07D471/04C07D471/14C07D471/16C07D487/04
    • Briefly described, embodiments of this disclosure include compounds as described herein, labeled compounds as described herein, pharmaceutical composition including compounds described herein, methods of imaging, method of forming a compound as described herein, and the like. In particular, embodiments of the disclosure include a series of triamino-pyridine derivatives and labeled triamino-pyridine derivatives, methods of synthesizing these compounds, intermediate compounds, methods of treatment using these compounds, methods of imaging, diagnosing, localizing, monitoring, and/or assessing a condition (e.g., corticotropin releasing factor type-1 (CRF1)) and/or related biological events, using triamino-pyridine derivatives, and the like. In addition, the present disclosure includes compositions (e.g., labeled triamino-pyridine derivatives that are ligands for the CRF1 receptor) used in and methods relating to non-invasive imaging (e.g., positron emission tomography (PET) imaging or SPECT imaging).
    • 简要描述,本公开的实施方案包括本文所述的化合物,本文所述的标记化合物,包含本文所述化合物的药物组合物,成像方法,形成本文所述的化合物的方法等。 特别地,本公开的实施方案包括一系列三氨基 - 吡啶衍生物和标记的三氨基 - 吡啶衍生物,合成这些化合物的方法,中间体化合物,使用这些化合物的治疗方法,成像,诊断,定位,监测和/ 或使用三氨基 - 吡啶衍生物评估病症(例如促肾上腺皮质激素释放因子1型(CRF1))和/或相关的生物学事件等。 此外,本公开内容包括组合物(例如,用作CRF1受体的配体的标记的三氨基 - 吡啶衍生物)和与非侵入性成像(例如,正电子发射断层摄影(PET)成像或SPECT成像)有关的方法和方法。
    • 4. 发明申请
    • IMAGING AGENTS
    • 成像代理
    • WO2007001940A3
    • 2007-06-07
    • PCT/US2006023699
    • 2006-06-19
    • UNIV EMORYGOODMAN MARK M
    • GOODMAN MARK M
    • A61K51/00C07C61/04C07D345/00C07F13/00
    • C07C229/48A61K51/0402A61K51/0406C07B59/001C07C2601/04C07D291/04C07D345/00C07F13/005
    • The present invention provides novel amino acid compounds useful in detecting and evaluating brain and body tumors. These compounds have the advantageous properties of rapid uptake and prolonged retention in tumors and can be labeled with halogen isotopes such as fluorine-18, iodine-123, iodine-124, iodine-125, iodine-131, bromine-75, bromine-76, bromine-77, bromine-82, astatine-210, astatine-211, and other astatine isotopes. These compounds can also be labeled with technetium and rhenium isotopes using known chelation complexes. The compounds disclosed herein bind tumor tissues in vivo with high specificity and selectivity when administered to a subject. Preferred compounds show a target to non-target ratio of at least 2:1, are stable in vivo and substantially localized to target within 1 hour after administration. Preferred compounds include 2-[ 18 F]FACBC and 2-[ 18 F]FMACBC. The labeled amino acid compounds of the invention are useful as imaging agents in detecting and/or monitoring tumors in a subject by PET or SPECT.
    • 本发明提供了可用于检测和评估脑和体肿瘤的新型氨基酸化合物。 这些化合物具有在肿瘤中快速摄取和延长保留的有利特性,并且可以用卤素同位素如氟-18,碘-123,碘-124,碘-125,碘-131,溴-75,溴-76 ,溴-77,溴-82,ast ine -21,ast ine -211和其他ast同位素。 这些化合物也可以使用已知的螯合络合物用锝和铼同位素标记。 当给予受试者时,本文所公开的化合物以高特异性和选择性在体内结合肿瘤组织。 优选的化合物显示至少2:1的目标与非目标比例,在给药后1小时内在体内是稳定的并且基本上定位于靶标上。 优选的化合物包括2 - [SUP 18 F] FACBC和2 - [SUP 18 F] FMACBC。 本发明的标记氨基酸化合物可用作通过PET或SPECT检测和/或监测受试者的肿瘤的成像剂。
    • 6. 发明申请
    • IMAGING AGENTS
    • 成像剂
    • WO2007001940A2
    • 2007-01-04
    • PCT/US2006/023699
    • 2006-06-19
    • EMORY UNIVERSITYGOODMAN, Mark, M.
    • GOODMAN, Mark, M.
    • A61K51/00C07F13/00C07D345/00C07C61/04
    • C07C229/48A61K51/0402A61K51/0406C07B59/001C07C2601/04C07D291/04C07D345/00C07F13/005
    • The present invention provides novel amino acid compounds useful in detecting and evaluating brain and body tumors. These compounds have the advantageous properties of rapid uptake and prolonged retention in tumors and can be labeled with halogen isotopes such as fluorine-18, iodine-123, iodine-124, iodine-125, iodine-131, bromine-75, bromine-76, bromine-77, bromine-82, astatine-210, astatine-211, and other astatine isotopes. These compounds can also be labeled with technetium and rhenium isotopes using known chelation complexes. The compounds disclosed herein bind tumor tissues in vivo with high specificity and selectivity when administered to a subject. Preferred compounds show a target to non-target ratio of at least 2:1, are stable in vivo and substantially localized to target within 1 hour after administration. Preferred compounds include 2-[ 18 F]FACBC and 2-[ 18 F]FMACBC. The labeled amino acid compounds of the invention are useful as imaging agents in detecting and/or monitoring tumors in a subject by PET or SPECT.
    • 本发明提供了用于检测和评估脑和身体肿瘤的新型氨基酸化合物。 这些化合物具有在肿瘤中快速摄取和延长滞留的有利特性,并且可以用卤素同位素如氟-18,碘-123,碘-124,碘-125,碘-131,溴-75,溴-76 ,溴-77,溴-82,ast -210,ast -211和其他ast同位素。 这些化合物也可以使用已知的螯合络合物用锝和铼同位素标记。 本文公开的化合物在施用于受试者时以高特异性和选择性在体内结合肿瘤组织。 优选的化合物显示至少2:1的非靶标比率的靶标,在体内稳定并且在给药后1小时内基本上定位于靶标。 优选的化合物包括2 - [18 F] FACBC和2 - [18 F] FMACBC。 本发明的标记的氨基酸化合物可用作通过PET或SPECT检测和/或监测受试者中的肿瘤的显像剂。
    • 7. 发明申请
    • METHOD AND APPARATUS FOR ONLINE HEALTH MONITORING
    • 在线健康监测方法与装置
    • WO0129688A9
    • 2002-08-01
    • PCT/US0028899
    • 2000-10-16
    • UE SYSTEMS INCO'HANLON TERRENCE JBANDES ALAN SGOODMAN MARK AOSTERER MICHAEL F
    • O'HANLON TERRENCE JBANDES ALAN SGOODMAN MARK AOSTERER MICHAEL F
    • A61B5/00A61B5/022G06F19/00G06Q50/24G06F15/42
    • G06Q50/24G06F19/3418G06F19/3456G16H10/20G16H10/60G16H40/63G16H50/30
    • Methods for providing online health monitoring (16) and accumulating data from patients worldwide and accompanying apparatus for using the same, are disclosed. Such monitoring is particularly useful for both diagnosing and prescribing preventive medical treatment, and is particularly suited for the field of cardiovascular health care. Preferred methods and devices include using a sensitive acoustic device such as an electret, to analyze a patient's cardiovascular functions from a location such as a public computer kiosk, a doctor's office or a patient's home computer. The data may be downloaded from an acoustic device to a central database located, for example on the Internet. The data may be retrieved by the patient, or upon instructions from the patient, may be transferred to or accessed by doctors for purposes of diagnosis, monitoring and treatment. Data may include patient demographics. This data is accessible by researchers who will have medical statistics on a wide variety of patients from various age groups and medical histories.
    • 公开了用于提供在线健康监测(16)和累积来自世界各地患者的数据的方法以及使用其的伴随装置。 这种监测对诊断和处方预防性治疗特别有用,特别适用于心血管保健领域。 优选的方法和装置包括使用诸如驻极体的敏感的声学装置从诸如公共计算机信息亭,医生办公室或患者的家庭计算机的位置分析患者的心血管功能。 数据可以从声学装置下载到例如位于因特网上的中央数据库。 为了诊断,监测和治疗的目的,可以由患者检索数据,或者根据患者的指示将其转移到医生或由医生访问。 数据可能包括患者人口统计。 研究人员可以访问这些数据,这些研究人员将对来自不同年龄组和病史的各种患者进行医学统计。